• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

HCC screening with non-contrast MRI and alpha-fetoprotein: combining a new player with an old friend.

作者信息

Amorim João

机构信息

Radiology Department, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal.

School of Medicine, University of Minho, Braga, Portugal.

出版信息

Eur Radiol. 2023 Oct;33(10):6927-6928. doi: 10.1007/s00330-023-09934-0. Epub 2023 Aug 7.

DOI:10.1007/s00330-023-09934-0
PMID:37548693
Abstract
摘要

相似文献

1
HCC screening with non-contrast MRI and alpha-fetoprotein: combining a new player with an old friend.使用非增强磁共振成像和甲胎蛋白进行肝癌筛查：将新方法与老方法相结合。
Eur Radiol. 2023 Oct;33(10):6927-6928. doi: 10.1007/s00330-023-09934-0. Epub 2023 Aug 7.
2
Spontaneous regression of hepatocellular carcinoma.肝细胞癌的自发消退
Indian J Gastroenterol. 2012 Sep;31(5):267-70. doi: 10.1007/s12664-012-0220-2. Epub 2012 Aug 15.
3
Decreasing Trend of Serum α-Fetoprotein Level in Hepatocellular Carcinoma.肝细胞癌患者血清甲胎蛋白水平的下降趋势
Clin Gastroenterol Hepatol. 2022 May;20(5):1177-1179.e4. doi: 10.1016/j.cgh.2021.08.011. Epub 2021 Aug 12.
4
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.更新血液生物标志物及其算法在肝细胞癌诊断和监测中的临床应用：批判性评价。
Int J Mol Sci. 2023 Feb 21;24(5):4286. doi: 10.3390/ijms24054286.
5
A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.一位 70 岁女性，甲胎蛋白测量值显著升高达 10 年。
Semin Liver Dis. 2010 Feb;30(1):99-106. doi: 10.1055/s-0030-1247136. Epub 2010 Feb 19.
6
Diagnosis and staging of hepatocellular carcinoma.肝细胞癌的诊断与分期
Gastroenterology. 2004 Nov;127(5 Suppl 1):S126-32. doi: 10.1053/j.gastro.2004.09.026.
7
VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.血管性血友病因子/解整合素金属蛋白酶 13 比值作为肝细胞癌早期检测的潜在生物标志物。
BMC Gastroenterol. 2019 Oct 21;19(1):167. doi: 10.1186/s12876-019-1082-1.
8
A commentary on "Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study" (Int J Surg 2022;105:106843).关于《维生素K缺乏诱导蛋白-II与甲胎蛋白在检测可切除肝细胞癌及肝切除术后早期复发中的比较：一项回顾性队列研究》（《国际外科学杂志》2022年；第105卷：第106843页）的述评
Int J Surg. 2022 Oct;106:106910. doi: 10.1016/j.ijsu.2022.106910. Epub 2022 Sep 20.
9
Diagnostic performance of tumor markers AFP and PIVKA-II in Chinese hepatocellular carcinoma patients.肿瘤标志物甲胎蛋白（AFP）和异常凝血酶原（PIVKA-II）在中国肝细胞癌患者中的诊断效能
Tumour Biol. 2017 Jun;39(6):1010428317705763. doi: 10.1177/1010428317705763.
10
Hepatocellular carcinoma as a rare cause of an excessive increase in alpha-fetoprotein during pregnancy.肝细胞癌是孕期甲胎蛋白过度升高的罕见原因。
Gynecol Oncol. 1996 Sep;62(3):405-7. doi: 10.1006/gyno.1996.0257.

本文引用的文献

1
The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening.非对比性缩短磁共振成像与甲胎蛋白联合检测对肝细胞癌筛查具有较高的性能。
Eur Radiol. 2023 Oct;33(10):6929-6938. doi: 10.1007/s00330-023-09906-4. Epub 2023 Jul 18.
2
Abbreviated MRI with second shot arterial phase for HCC evaluation: modified version of LI-RADS and recall reduction strategy.用于 HCC 评估的缩短型 MRI 第二射动脉期：LI-RADS 修订版和召回策略。
Eur Radiol. 2023 Jun;33(6):4401-4411. doi: 10.1007/s00330-022-09348-4. Epub 2022 Dec 23.
3
Abbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis.
用于肝细胞癌筛查的简化 MRI：系统评价和荟萃分析。
J Hepatol. 2021 Jul;75(1):108-119. doi: 10.1016/j.jhep.2021.01.041. Epub 2021 Feb 3.
4
Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.致密型乳腺女性的补充性磁共振成像筛查。
N Engl J Med. 2019 Nov 28;381(22):2091-2102. doi: 10.1056/NEJMoa1903986.
5
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.肝细胞癌监测：当前最佳实践和未来方向。
Gastroenterology. 2019 Jul;157(1):54-64. doi: 10.1053/j.gastro.2019.02.049. Epub 2019 Apr 12.
6
Hepatocellular Carcinoma.肝细胞癌
N Engl J Med. 2019 Apr 11;380(15):1450-1462. doi: 10.1056/NEJMra1713263.
7
Surveillance for hepatocellular carcinoma is associated with increased survival: Results from a large cohort in the Netherlands.肝癌监测与生存率提高相关：来自荷兰大型队列研究的结果。
J Hepatol. 2015 Nov;63(5):1156-63. doi: 10.1016/j.jhep.2015.06.012. Epub 2015 Jun 20.
8
Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail?在 HALT-C 试验中，晚期肝细胞癌患者的检测：监测在哪里失败了？
Am J Gastroenterol. 2013 Mar;108(3):425-32. doi: 10.1038/ajg.2012.449. Epub 2013 Jan 22.